Xiao Li
- Cancer Research top 2%
- MicroRNA in disease regulation 23
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 27
- Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology 23
- Immunology top 2%
- Virology top 5%
-
- Virus-based gene therapy research 69
-
- Autophagy in Disease and Therapy 24
- Herpesvirus Infections and Treatments 20
-
- Lung Cancer Diagnosis and Treatment 20
- Ferroptosis and cancer prognosis 19
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiao Li
564 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 1.0k
- Molecular Biology 3.8k
- Infectious Diseases 939
- Immunology 969
- Virology 206
Countries citing papers authored by Xiao Li
This map shows the geographic impact of Xiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Li more than expected).
Fields of papers citing papers by Xiao Li
This network shows the impact of papers produced by Xiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Li. The network helps show where Xiao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 32 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 13 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 9 | |
| 18 | 2023 | 76 | |
| 19 | 2022 | 1 | |
| 20 | 2008 | 27 |
About Xiao Li
Xiao Li is a scholar working on Virology, Cancer Research and Molecular Biology, having authored 593 papers that have together received 9.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (69 papers), RNA Interference and Gene Delivery (27 papers), Autophagy in Disease and Therapy (24 papers), MicroRNA in disease regulation (23 papers), Viral gastroenteritis research and epidemiology (23 papers), Herpesvirus Infections and Treatments (20 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Ferroptosis and cancer prognosis (19 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (3.8k citations) and Infectious Diseases (939 citations). Xiao Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ningyi Jin, Junhu Zhang, Bai Yang, Chang Li, Yilong Zhu, Mingyao Tian, Lili Sun, Tieqiang Wang, Makoto Takeda and Jun‐ichiro Inoue. Their work appears in journals such as Frontiers in Oncology, Virus Research, PLoS ONE, Scientific Reports and Langmuir.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.